Bicalutamide having Long Half Life [Design Issues]

posted by udayk – India, 2019-10-04 10:06 (567 d 01:04 ago) – Posting: # 20664
Views: 1,953

Dear All,

We need clarification on study design of BE of Bicalutamide 50mg tablets since, its long half life is around 150 hours and most of the available literatures have shown as parallel BE study with last time point as 672 hours and two-way cross over study with last time point as 672 hours.

Please suggest on study design of BE/BA study with Time-points to cover the AUC.

Regards,
Udaya Kumar K.
Biostatistician

Complete thread:

Activity
 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 8 (0 registered, 8 guests [including 4 identified bots]).
Forum time: Friday 11:11 UTC (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5